全文获取类型
收费全文 | 5058篇 |
免费 | 276篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 153篇 |
妇产科学 | 107篇 |
基础医学 | 643篇 |
口腔科学 | 229篇 |
临床医学 | 306篇 |
内科学 | 1140篇 |
皮肤病学 | 236篇 |
神经病学 | 392篇 |
特种医学 | 121篇 |
外科学 | 642篇 |
综合类 | 14篇 |
预防医学 | 234篇 |
眼科学 | 94篇 |
药学 | 360篇 |
中国医学 | 13篇 |
肿瘤学 | 546篇 |
出版年
2024年 | 9篇 |
2023年 | 45篇 |
2022年 | 72篇 |
2021年 | 154篇 |
2020年 | 82篇 |
2019年 | 119篇 |
2018年 | 143篇 |
2017年 | 103篇 |
2016年 | 117篇 |
2015年 | 141篇 |
2014年 | 187篇 |
2013年 | 195篇 |
2012年 | 351篇 |
2011年 | 371篇 |
2010年 | 199篇 |
2009年 | 173篇 |
2008年 | 300篇 |
2007年 | 291篇 |
2006年 | 275篇 |
2005年 | 287篇 |
2004年 | 336篇 |
2003年 | 280篇 |
2002年 | 246篇 |
2001年 | 94篇 |
2000年 | 97篇 |
1999年 | 77篇 |
1998年 | 44篇 |
1997年 | 40篇 |
1996年 | 37篇 |
1995年 | 33篇 |
1994年 | 17篇 |
1993年 | 21篇 |
1992年 | 40篇 |
1991年 | 45篇 |
1990年 | 60篇 |
1989年 | 35篇 |
1988年 | 35篇 |
1987年 | 32篇 |
1986年 | 35篇 |
1985年 | 30篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 14篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1973年 | 6篇 |
1972年 | 5篇 |
排序方式: 共有5361条查询结果,搜索用时 0 毫秒
71.
Satoshi Kutsuna Yusuke Asai Kei Yamamoto Michinori Shirano Keiji Konishi Tomohiro Asaoka Masaya Yamato Yukiko Katsuragi Yudai Yamamoto Toshinori Sahara Aya Tamiya Fukumi Nakamura-Uchiyama Naoya Sakamoto Atsushi Kosaka Takuya Washino Ryota Hase Haruki Mito Takashi Kurita Norio Ohmagari 《Journal of infection and chemotherapy》2021,27(4):632-638
IntroductionThe epidemiology of infectious diseases in Japan remains undefined despite the increasing tourism. GeoSentinel, an epidemiological surveillance system for reporting imported infectious diseases, has only two participating facilities in Japan. Although the number of infectious diseases is reported by the National Institute of Infectious Diseases, there is no detailed clinical information about these cases. Therefore, we established J-RIDA (Japan Registry for Infectious Diseases from Abroad) to clarify the status of imported infectious diseases in Japan and provide detailed information.MethodsJ-RIDA was started as a registry of imported infectious diseases. Case registration began in October 2017. Between October 2017 and September 2019, 15 medical institutions participated in this clinical study. The registry collected information about the patient's age, sex, nationality, chief complaint, consultation date, date of onset, whether visit was made to a travel clinic before travel, blood test results (if samples were collected), travel history, and final diagnosis.ResultsOf the 3046 cases included in this study, 46.7% to Southeast Asia, 13.0% to Africa, 13.7% to East Asia, 11.5% to South Asia, 7.5% to Europe, 3.8% to Central and South America, 4.6% to North America, 3.9% to Oceania, and 2.8% to Central and west Asia. More than 85% of chief complaints were fever and general symptoms, gastrointestinal symptoms, respiratory symptoms, or dermatologic problems. The most common diseases were travelers’ diarrhea, animal bite, upper respiratory infection, influenza, and dengue fever.ConclusionsWe summarized two-year cases registered in Japan's imported infectious disease registry. These results will significantly contribute to the epidemiology in Japan. 相似文献
72.
Nobuyuki Ashizawa Takahiro Takazono Kaname Ohyama Yoji Nagasaki Masaki Okamoto Tatsuro Hirayama Kensuke Takahashi Hirotomo Yamanashi Masato Tashiro Naoki Hosogaya Takeshi Tanaka Kazuko Yamamoto Yuichi Fukuda Yoshifumi Imamura Toshinori Kawanami Taiga Miyazaki Toyomitsu Sawai Kiyoyasu Fukushima Hiroshi Mukae 《Journal of infection and chemotherapy》2021,27(7):1033-1038
IntroductionNumerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests exists commercially; however, their performance using clinical samples is limited. Although insufficient to detect SARS-CoV-2 in the early phase of infection, antibody assays can be of great use for surveillance studies or for some coronavirus disease 2019 (COVID-19) patients presenting late to the hospital.MethodsThis study evaluated the sensitivity and specificity of four commercial SARS-CoV-2 lateral flow antibody tests using 213 serum specimens from 90 PCR-positive confirmed COVID-19 patients. Of 59 negative control sera, 50 were obtained from patients with other respiratory infectious diseases before COVID-19 pandemic began while nine were from patients infected with other respiratory viruses, including two seasonal coronaviruses.ResultsThe varied sensitivities for the four commercial kits were 70.9%, 65.3%, 45.1%, and 65.7% for BioMedomics, Autobio Diagnostics, Genbody, and KURABO, respectively, between sick days 1 and 155 in COVID-19 patients. The sensitivities of the four tests gradually increased over time after infection before sick day 5 (15.0%, 12.5%, 15.0%, and 20.0%); from sick day 11–15 (95.7%, 87.2%, 53.2%, and 89.4%); and after sick day 20 (100%, 100%, 68.6%, and 96.1%), respectively. For severe illness, the sensitivities were quite high in the late phase after sick day 15. The specificities were over 96% for all four tests. No cross-reaction due to other pathogens, including seasonal coronaviruses, was observed.ConclusionsOur results demonstrated the large differences in the antibody test performances. This ought to be considered when performing surveillance analysis. 相似文献
73.
74.
75.
Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi‐institutional national database of the Japanese Urological Association 下载免费PDF全文
76.
77.
78.
Hiroko P. Indo Hsiu-Chuan Yen Ikuo Nakanishi Ken-ichiro Matsumoto Masato Tamura Yumiko Nagano Hirofumi Matsui Oleg Gusev Richard Cornette Takashi Okuda Yukiko Minamiyama Hiroshi Ichikawa Shigeaki Suenaga Misato Oki Tsuyoshi Sato Toshihiko Ozawa Daret K. St. Clair Hideyuki J. Majima 《Journal of Clinical Biochemistry and Nutrition》2015,56(1):1-7
Fridovich identified CuZnSOD in 1969 and manganese superoxide dismutase (MnSOD) in 1973, and proposed ”the Superoxide Theory,” which postulates that superoxide (O2•−) is the origin of most reactive oxygen species (ROS) and that it undergoes a chain reaction in a cell, playing a central role in the ROS producing system. Increased oxidative stress on an organism causes damage to cells, the smallest constituent unit of an organism, which can lead to the onset of a variety of chronic diseases, such as Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis and other neurological diseases caused by abnormalities in biological defenses or increased intracellular reactive oxygen levels. Oxidative stress also plays a role in aging. Antioxidant systems, including non-enzyme low-molecular-weight antioxidants (such as, vitamins A, C and E, polyphenols, glutathione, and coenzyme Q10) and antioxidant enzymes, fight against oxidants in cells. Superoxide is considered to be a major factor in oxidant toxicity, and mitochondrial MnSOD enzymes constitute an essential defense against superoxide. Mitochondria are the major source of superoxide. The reaction of superoxide generated from mitochondria with nitric oxide is faster than SOD catalyzed reaction, and produces peroxynitrite. Thus, based on research conducted after Fridovich’s seminal studies, we now propose a modified superoxide theory; i.e., superoxide is the origin of reactive oxygen and nitrogen species (RONS) and, as such, causes various redox related diseases and aging. 相似文献
79.
80.
Surgery for synchronous colorectal cancers with double colonic anastomoses: A comparison of laparoscopic and open approaches 下载免费PDF全文